Literature DB >> 17928611

ERCC1-specific immunostaining in non-small-cell lung cancer.

Ken A Olaussen, Pierre Fouret, Guido Kroemer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17928611     DOI： 10.1056/NEJMc072007

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  17 in total

1.  The XPA-binding domain of ERCC1 is required for nucleotide excision repair but not other DNA repair pathways.

Authors:  Barbara Orelli; T Brooke McClendon; Oleg V Tsodikov; Tom Ellenberger; Laura J Niedernhofer; Orlando D Schärer
Journal:  J Biol Chem       Date:  2009-11-23       Impact factor: 5.157

2.  Adjuvant immunotherapy in resected early non-small cell lung cancer-battle lost, hopefully not the war!

Authors:  Branislav Jeremic; Nikola Cihoric; Pavol Dubinsky; Nenad Filipovic
Journal:  J Thorac Dis       Date:  2016-08       Impact factor: 2.895

Review 3.  Prognostic value of ERCC1 mRNA expression in non-small cell lung cancer, breast cancer, and gastric cancer in patients from Southern China.

Authors:  Qiuhua Deng; Haihong Yang; Yongping Lin; Yuan Qiu; Xia Gu; Ping He; Meiling Zhao; Hui Wang; Yunjian Xu; Yunen Lin; Juhong Jiang; Jianxing He; Jeff X Zhou
Journal:  Int J Clin Exp Pathol       Date:  2014-12-01

4.  Commercial laboratory testing of excision repair cross-complementation group 1 expression in non-small cell lung cancer.

Authors:  Jeffrey G Schneider; Nosha Farhadfar; Abirami Sivapiragasam; Matthew Geller; Shahidul Islam; Elena Selbs
Journal:  Oncologist       Date:  2014-04-04

5.  ERCC1 isoform expression and DNA repair in non-small-cell lung cancer.

Authors:  Luc Friboulet; Ken André Olaussen; Jean-Pierre Pignon; Frances A Shepherd; Ming-Sound Tsao; Stephen Graziano; Robert Kratzke; Jean-Yves Douillard; Lesley Seymour; Robert Pirker; Martin Filipits; Fabrice André; Eric Solary; Florence Ponsonnailles; Angélique Robin; Annabelle Stoclin; Nicolas Dorvault; Frédéric Commo; Julien Adam; Elsa Vanhecke; Patrick Saulnier; Jürgen Thomale; Thierry Le Chevalier; Ariane Dunant; Vanessa Rousseau; Gwénaël Le Teuff; Elisabeth Brambilla; Jean-Charles Soria
Journal:  N Engl J Med       Date:  2013-03-21       Impact factor: 91.245

6.  Immunodetection of DNA repair endonuclease ERCC1-XPF in human tissue.

Authors:  Nikhil R Bhagwat; Vera Y Roginskaya; Marie B Acquafondata; Rajiv Dhir; Richard D Wood; Laura J Niedernhofer
Journal:  Cancer Res       Date:  2009-09-01       Impact factor: 12.701

7.  ERCC1 Expression Analysis to Guide Therapy in Non-Small Cell Lung Cancer.

Authors:  Diane Allingham-Hawkins; Andrew Lea; Susan Levine
Journal:  PLoS Curr       Date:  2010-12-06

8.  Automated ERCC1 immunochemistry on hybrid cytology/tissue microarray of malignant effusions: evaluation of antibodies 8F1 and D-10.

Authors:  Alex Soltermann; Sandra Kilgus-Hawelski; Silvia Behnke; Martina Storz; Holger Moch; Beata Bode
Journal:  J Clin Bioinforma       Date:  2011-09-30

9.  Loss-of-function alleles of P2RX7 and TLR4 fail to affect the response to chemotherapy in non-small cell lung cancer.

Authors:  Erika Vacchelli; Lorenzo Galluzzi; Vanessa Rousseau; Alice Rigoni; Antoine Tesniere; Nicolas Delahaye; Fre de Ric Schlemmer; Laurie Menger; Abdul Qader Sukkurwala; Sandy Adjemian; Isabelle Martins; Mickaël Michaud; Ariane Dunant; Oliver Kepp; Elisabeth Brambilla; Jean-Charles Soria; Laurence Zitvogel; Guido Kroemer
Journal:  Oncoimmunology       Date:  2012-05-01       Impact factor: 8.110

Review 10.  The potential of exploiting DNA-repair defects for optimizing lung cancer treatment.

Authors:  Sophie Postel-Vinay; Elsa Vanhecke; Ken A Olaussen; Christopher J Lord; Alan Ashworth; Jean-Charles Soria
Journal:  Nat Rev Clin Oncol       Date:  2012-02-14       Impact factor: 66.675
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.